Semax (ACTH Fragment Peptide)

Semax Storage, Stability and Reconstitution

UKPWritten and published by UK Peptides2 min readUpdated 1 cited source

The short answer

Semax is supplied lyophilised and is most stable in that state, stored cold, dry and protected from light. Its proline content confers unusual resistance to enzymatic degradation and it contains no cysteine, so the main chemical liability is oxidation of its single methionine.

Key facts

Supplied as
White lyophilised powder
Main degradation route
Methionine oxidation (+16 Da)
Oxidation-prone residue
Met1 (one only)
Disulfide risk
None (no cysteine)
Enzymatic resistance
High (two prolines)
Lyophilised storage
Cold, dry, dark
Freeze-thaw
Avoid by aliquoting

Why the lyophilised form is the stable one

Freeze-drying removes water, and water participates in peptide-bond hydrolysis. A dry powder held cold has limited routes to degrade. This is general to research peptides rather than specific to Semax, and it is why the condition of material on arrival matters: a warm transit is time spent in a less protected state.

What makes Semax comparatively robust

Two features. Its proline content resists most peptidases, which is the property the Pro-Gly-Pro extension was added to provide. And at seven residues it is short, with correspondingly few bonds available to hydrolyse. Compared with a 39-residue lipidated peptide, this is a straightforward molecule to keep intact.

Research material referenced

Semax 10mg, third-party HPLC tested

Buy Semax · £24.99

The one real liability

Methionine at position 1. Its thioether sulfur oxidises to the sulfoxide in the presence of dissolved oxygen, accelerated by light and heat, adding 16 Da. This is the reason cold, dark, dry storage is specifically indicated rather than generically advised. With one methionine, a degraded sample shows a +16 satellite; a +32 peak would indicate something other than simple methionine oxidation and is worth investigating.

What does not apply

No cysteine means no disulfide formation, no scrambling and no reducing agent in buffers. That removes a whole category of handling complexity present for cysteine-containing peptides.

Reconstitution

Bacteriostatic water (sterile water preserved with 0.9% benzyl alcohol) is the usual diluent for research peptides, permitting repeated entry over a limited window. Introduce solvent gently against the vial wall rather than directing it onto the powder, and swirl rather than shake. Shaking creates an air-liquid interface at which peptides denature; foaming is the visible sign it has happened.

After reconstitution

Solution-phase material is subject to hydrolysis and oxidation, and stability falls accordingly. Aliquot into single-use volumes rather than freeze-thawing repeatedly, since each cycle concentrates solutes at the advancing ice boundary and exposes the peptide to interfaces. Cloudiness, particulates or discolouration mean the material should not be relied on for a measurement.

Frequently asked questions

Is Semax more stable than most research peptides?

In enzymatic terms, yes: the proline content is there for that. Chemically, its methionine still oxidises like any other.

Does Semax need a reducing agent?

No. Reducing agents address disulfide chemistry, and there is no cysteine in the sequence.

Why swirl instead of shake?

Shaking generates an air-liquid interface where peptides denature. Foam is the visible evidence.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Semax (ACTH Fragment Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.